Carlos A. Zarate, M.D.
Affiliations: | National Institute of Mental Health, Bethesda, MD, United States |
Area:
Depression, KetamineGoogle:
"Carlos Zarate"Mean distance: 16.18 (cluster 29)
Children
Sign in to add trainee| Nancy B. Lundin | research assistant | 2013-2015 | National Institute of Mental Health (NIMH) |
| Anahit Mkrtchian | grad student | National Institute of Mental Health (NIMH) | |
| Katherine Xie | grad student | ||
| Níall Lally | grad student | 2011-2015 | National Institute of Mental Health (NIMH) |
| Jessica L. (Ihne) Reed | post-doc | 2014- | NIMH |
| Jessica R Gilbert | research scientist | 2017- | NIMH |
| Paule Valery Joseph | research scientist | 2020- | National Institute for Mental Health |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Ballard ED, Nischal RP, Burton CR, et al. (2024) Clinical and electrophysiological correlates of hopelessness in the context of suicide risk. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 80: 38-45 |
| Alexander L, Hawkins PCT, Evans JW, et al. (2023) Preliminary evidence that ketamine alters anterior cingulate resting-state functional connectivity in depressed individuals. Translational Psychiatry. 13: 371 |
| Lamontagne SJ, Gilbert JR, Zabala PK, et al. (2023) Clinical, behavioral, and electrophysiological profiles along a continuum of suicide risk: evidence from an implicit association task. Psychological Medicine. 1-10 |
| Wang PR, Yavi M, Lee H, et al. (2023) An Open-Label Study of Adjunctive Dextromethorphan/Quinidine in Treatment-Resistant Depression. Journal of Clinical Psychopharmacology. 43: 422-427 |
| Punturieri C, Duncan WC, Greenstein D, et al. (2023) An exploration of actigraphy in the context of ketamine and treatment-resistant depression. International Journal of Methods in Psychiatric Research. e1984 |
| Nikolin S, Rodgers A, Schwaab A, et al. (2023) Ketamine for the treatment of major depression: a systematic review and meta-analysis. Eclinicalmedicine. 62: 102127 |
| Machado-Vieira R, Courtes AC, Zarate CA, et al. (2023) Non-canonical pathways in the pathophysiology and therapeutics of bipolar disorder. Frontiers in Neuroscience. 17: 1228455 |
| Kotoula V, Evans JW, Punturieri CE, et al. (2023) Review: The use of functional magnetic resonance imaging (fMRI) in clinical trials and experimental research studies for depression. Frontiers in Neuroimaging. 2: 1110258 |
| Wang PR, Yavi M, Lee H, et al. (2023) An Open-Label Study of Adjunctive Dextromethorphan/Quinidine in Treatment-Resistant Depression. Journal of Clinical Psychopharmacology |
| Johnston JN, Kadriu B, Kraus C, et al. (2023) Ketamine in neuropsychiatric disorders: an update. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology |